The Carotid Center

Filter Your Results

 

News

 

Data Presented on Silk Road Medical’s Enroute Neuroprotection System

June 15, 2016 -- Silk Road Medical, Inc. announced that data for the company’s Enroute transcarotid neuroprotection and stent system were presented at the Society for Va…

Cost-Utility Analysis Compares CAS Versus CEA in the International Carotid Stenting Study

May 10, 2016 -- A comparison of the cost effectiveness of carotid artery stenting (CAS) versus carotid endarterectomy (CEA) using data from the International Carotid Stenting …

Study of Medicare Patients Finds Comparable Outcomes for CAS and CEA

April 29, 2016 -- A study of the effectiveness of carotid artery stenting (CAS) versus carotid endarterectomy (CEA) among Medicare beneficiaries concluded that the outcomes af…

CREST Findings on Angiographic Characteristics Contributing to Periprocedural CAS Stroke and Death Risk Published

April 20, 2016 -- The higher stroke and death (S+D) risk for patients treated with carotid artery stenting (CAS) in CREST, the Carotid Revascularization Endarterectomy Versus …

FDA Clears Silk Road Medical’s Next-Generation Enroute Transcarotid Neuroprotection System

April 13, 2016 -- Silk Road Medical, Inc. announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s next-generation Enroute…

CAS and CEA Show Equal Safety and Efficacy at Lowering Long-Term Stroke Risk in 10-Year CREST Results

March 21, 2016 -- The Mayo Clinic in Jacksonville, Florida, recently announced that the 10-year findings from the CREST (Carotid Revascularization Endarterectomy Ver…

Five-Year ACT-1 Data Show CAS as Effective as CEA for Stroke Prevention in Asymptomatic Patients

March 21, 2016 -- The 5-year findings from ACT 1, the Asymptomatic Carotid Trial, were published by Kenneth Rosenfield, MD, et al in The New England Journal of Medicine (…

Thirty-Day CAS Results Published From the International Carotid Stenting Study

March 18, 2016 -- Findings on the effect of baseline patient demographic factors, processes of care, and technical factors during carotid artery stenting (CAS) on the risk of …

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.